EUCTR2011-002833-20-GB进行中（未招募）1 期
Prospective study of 18F-RGD PET-CT in assessment of response to antiangiogenic treatment in patients with renal cancer and comparison with perfusion CT - RGD-PET in Kidney Cancer angiogenesis
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •A patient will be eligible for inclusion in this study if all of the following criteria apply:
- •1Patients should have advanced or metastatic RCC confirmed by histological diagnosis
- •2Patients considered suitable for therapy with TKI according to responsible clinician
- •3Measurable tumour according to RECIST v1.1 criteria
- •4Standard staging CT scan performed within 28 days of first research scan
- •5The patient has not received chemotherapy, radiotherapy, surgery or any other treatment against cancer within 4 weeks prior to recruitment
- •6Age =18 years
- •7Adequate renal function (creatinine <1.25xULN)
- •8Patient is able to tolerate and comply with scanning procedure
- •9Patient is not lactating or pregnant
- •10Patient is not known or suspected to have a hypersensitivity or allergy to Fluciclatide (18F) Injection or any of its components (including pABA).
- •11Absence of any psychological, familial, sociological or geographical condition which in the opinion of the Investigator may potentially hamper compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial
- •12Able and willing to give informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 12
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 38
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.Advanced or recurrent lung cancerJPRN-UMIN000053550iigata University Medical and Dental Hospital165
Unknown
早期 1 期
18F-FDG PET/CT for IgG4-Related DiseaseAutoimmune DiseaseNCT01665196Peking Union Medical College Hospital100
尚未招募
不适用
To study the role of FDG PET-CT in patients with lower back spinal pain for localization of active site generating pain and causing pain symptoms.CTRI/2022/09/046021ot applicable
已完成
不适用
Early response evaluation with 18F-FDG PET/CT and immunological profiling of circulating immune cells and tumor-draining lymph nodes in non-small cell lung cancer patients treated with immunotherapy.lung cancerNL-OMON48669Antoni van Leeuwenhoek Ziekenhuis50
终止
2 期
RGD-PET-CT in Cancer AngiogenesisCarcinoma, Renal CellNCT01492192Oxford University Hospitals NHS Trust10